Concepcion Herrera Arroyo on Muck Rack

Concepcion Herrera Arroyo

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Concepcion Herrera

Contact Concepcion Herrera, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT | Bone Marrow Transplantation

|
By Jacques-Emmanuel Galimard, Marco Zecca, Alexander B. Mohseny, Alphan Küpesiz, Nuno Miranda, Tayfun Güngör, Robert F. Wynn, Pietro Merli, Mikael Sundin, Maura Faraci, Cristina Diaz-de-Heredia, Birgit Burkhardt, Victoria Bordón, Marianne Ifversen, Concepcion Herrera Arroyo, Natalia Maximova, Franco Locatelli, Krzysztof Kalwak, Clémence Aldebert
| Nature
Abstract Congenital amegakaryocytic thrombocytopenia is a rare, inherited bone marrow failure syndrome. Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is currently the only curative treatment. In this retrospective study, we analysed 66 patients with allo-HSCT, reported in the European Society for Blood and Marrow Transplantation (EBMT) registry.
Open in Who Shared Issue with article?

Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation

|
By Monika Engelhardt, Jürgen Kuball, Maria Mateos , Nicolaus Kröger, Jose M. Moraleda, Patrick J. Hayden, Meral Beksac, Donal McLornan, Stefan O. Schönland, Rémi Tilmont, Concepcion Herrera Arroyo
| Nature
Abstract In the setting of a first relapse of multiple myeloma (MM), a second autologous stem cell transplant (ASCT) following carfilzomib-lenalidomide-dexamethasone (KRd) is an option, although there is scarce data concerning this approach. We performed a retrospective study involving 22 EBMT-affiliated centers. Eligible MM patients had received a second-line treatment with KRd induction followed by a second ASCT between 2016 and 2018.
Open in Who Shared Issue with article?
See all 2 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Concepcion Herrera

Contact Concepcion Herrera, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified